BACE1 levels are elevated in AD patients, and thus it is likely that in addition to promoting increased levels of Aβ, it may also be responsible for the deficit in active Nav 1.1 proteins located in the cell membrane [41, 42]. The gene discussed is BACE1; the disease is Alzheimer disease.